Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wolf-K Hofmann

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Oncotarget|February 8, 2014
ERG induces a mesenchymal-like state associated with chemoresistance in leukemia cellsLiliana H Mochmann, Martin Neumann, Eva K von der Heide, et al.
The New England Journal of Medicine|February 14, 2009
Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantationGero Hütter, Daniel Nowak, Maximilian Mossner, et al.
Blood|February 7, 2002
Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein alpha in myelodysplastic syndromes and acute myeloid leukemiasAdrian F Gombart, Wolf-K Hofmann, Seiji Kawano, et al.
Leukemia Research|July 9, 2011
Clinical management of gastrointestinal disturbances in patients with myelodysplastic syndromes receiving iron chelation treatment with deferasiroxFlorian Nolte, Emanuele Angelucci, Photis Beris, et al.
International Journal of Cancer|March 18, 2004
Identifying progression-associated genes in adult T-cell leukemia/lymphoma by using oligonucleotide microarraysKunihiro Tsukasaki, Sakae Tanosaki, Sven DeVos, et al.
Palliative Medicine|March 23, 2026
A randomized controlled clinical trial of intranasal versus subcutaneous midazolam for agitation in terminal illness (MinTU study)Hanna Hirschinger, Constanze Rémi, Evelyn Jäger, et al.
Nature Medicine|January 25, 2005
Cathepsin L is required for endothelial progenitor cell-induced neovascularizationCarmen Urbich, Christopher Heeschen, Alexandra Aicher, et al.
British Journal of Haematology|October 8, 2016
Mammalian-target of rapamycin inhibition with temsirolimus in myelodysplastic syndromes (MDS) patients is associated with considerable toxicity: results of the temsirolimus pilot trial by the German MDS Study Group (D-MDS)Martin Wermke, Claudia Schuster, Florian Nolte, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Oncotarget|February 8, 2014
ERG induces a mesenchymal-like state associated with chemoresistance in leukemia cellsLiliana H Mochmann, Martin Neumann, Eva K von der Heide, et al.
The New England Journal of Medicine|February 14, 2009
Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantationGero Hütter, Daniel Nowak, Maximilian Mossner, et al.
Blood|February 7, 2002
Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein alpha in myelodysplastic syndromes and acute myeloid leukemiasAdrian F Gombart, Wolf-K Hofmann, Seiji Kawano, et al.
Leukemia Research|July 9, 2011
Clinical management of gastrointestinal disturbances in patients with myelodysplastic syndromes receiving iron chelation treatment with deferasiroxFlorian Nolte, Emanuele Angelucci, Photis Beris, et al.
International Journal of Cancer|March 18, 2004
Identifying progression-associated genes in adult T-cell leukemia/lymphoma by using oligonucleotide microarraysKunihiro Tsukasaki, Sakae Tanosaki, Sven DeVos, et al.
Palliative Medicine|March 23, 2026
A randomized controlled clinical trial of intranasal versus subcutaneous midazolam for agitation in terminal illness (MinTU study)Hanna Hirschinger, Constanze Rémi, Evelyn Jäger, et al.
Nature Medicine|January 25, 2005
Cathepsin L is required for endothelial progenitor cell-induced neovascularizationCarmen Urbich, Christopher Heeschen, Alexandra Aicher, et al.
British Journal of Haematology|October 8, 2016
Mammalian-target of rapamycin inhibition with temsirolimus in myelodysplastic syndromes (MDS) patients is associated with considerable toxicity: results of the temsirolimus pilot trial by the German MDS Study Group (D-MDS)Martin Wermke, Claudia Schuster, Florian Nolte, et al.
Pageof 6